Log in | Register

Mini Bioreactor System

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Mini Bioreactor System

The DASbox features the full functionality of industry bioreactors but takes up minimal lab space. Designed as four-fold modular system with working volumes of 60 to 250 mL, it provides the highest flexibility for bioprocess development. Modules can be linked up to 24 (and even more) parallel operating mini bioreactors. According to the company, it requires only 3 inches/7.7 cm of bench space per bioreactor and it is the world’s most compact, industry standard mini bioreactor system for cell culture and microbiology. A 24-fold system takes up approximately 6 feet/1.8 m of lab bench space. It is a perfect fit for clone and cell line screening as well as media optimization. It includes advanced temperature and agitation control, precise monitoring and control of pH and DO, and state-of-the-art multipump and gasmixing modules. It features a user-friendly operation design with integrated storage slots for unused bioreactor components, telescopic base for effortless handling, e.g. during sampling, and more. Combined with the company’s software solutions suite DASware, it supports the FDA’s QbD approach by providing comprehensive information management, integration of third-party analyzers, and DoE tools as well as remote access via PC, Notebook, iPhone and iPad.


DASGIP AG, Germany. www.dasgip.com or call +49 (0)2461-980-0

 

INTERPHEX 2012 Booth No. 3478

 

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter